BSE Live
Dec 05, 16:01Prev. Close
1818.60
Open Price
1815.55
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 05, 15:59Prev. Close
1818.30
Open Price
1819.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1805.30 (24)
| Balance Sheet of Sun Pharmaceutical Industries (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 207.12 | 207.12 | 103.56 | 103.56 | 103.56 | |
| Total Share Capital | 207.12 | 207.12 | 103.56 | 103.56 | 103.56 | |
| Reserves and Surplus | 25,378.61 | 18,317.83 | 14,886.17 | 12,132.22 | 9,379.76 | |
| Total Reserves and Surplus | 25,382.59 | 18,317.83 | 14,886.17 | 12,132.22 | 9,379.76 | |
| Total Shareholders Funds | 25,589.71 | 18,524.95 | 14,989.73 | 12,235.78 | 9,483.32 | |
| Minority Interest | 2,851.19 | 1,921.18 | 1,635.08 | 1,161.45 | 847.15 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 1,368.42 | 48.67 | 115.26 | 155.42 | 157.28 | |
| Deferred Tax Liabilities [Net] | 98.52 | 275.67 | 205.35 | 155.20 | 134.83 | |
| Other Long Term Liabilities | 186.34 | 9.14 | 8.94 | 8.93 | 6.68 | |
| Long Term Provisions | 2,532.34 | 2,601.62 | 787.06 | 138.73 | 13.00 | |
| Total Non-Current Liabilities | 4,185.62 | 2,935.10 | 1,116.61 | 458.28 | 311.79 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 6,227.92 | 2,440.34 | 82.95 | 109.57 | 207.78 | |
| Trade Payables | 3,153.83 | 1,328.26 | 1,356.53 | 992.72 | 689.88 | |
| Other Current Liabilities | 2,765.97 | 260.41 | 218.65 | 363.66 | 238.77 | |
| Short Term Provisions | 4,205.28 | 1,960.58 | 1,481.66 | 1,152.54 | 638.95 | |
| Total Current Liabilities | 16,353.00 | 5,989.59 | 3,139.79 | 2,618.49 | 1,775.38 | |
| Total Capital And Liabilities | 49,027.90 | 29,370.82 | 20,881.21 | 16,474.00 | 12,417.64 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 6,975.18 | 3,498.18 | 3,160.43 | 2,613.51 | 2,233.42 | |
| Intangible Assets | 2,006.33 | 1,484.48 | 1,354.09 | 316.03 | 287.96 | |
| Capital Work-In-Progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 7,319.16 | 3,989.58 | 3,944.18 | 2,252.38 | 1,984.87 | |
| Non-Current Investments | 598.87 | 787.56 | 1,106.35 | 588.96 | 346.01 | |
| Deferred Tax Assets [Net] | 1,850.16 | 1,186.69 | 917.59 | 683.51 | 500.06 | |
| Long Term Loans And Advances | 2,680.50 | 1,051.18 | 837.76 | 594.75 | 378.98 | |
| Other Non-Current Assets | 55.35 | 0.11 | 7.86 | 17.41 | 26.23 | |
| Total Non-Current Assets | 19,905.96 | 10,684.36 | 9,079.64 | 6,180.63 | 4,780.09 | |
| CURRENT ASSETS | ||||||
| Current Investments | 2,117.43 | 1,998.46 | 1,305.22 | 1,623.91 | 1,883.75 | |
| Inventories | 5,667.99 | 3,123.01 | 2,577.76 | 2,086.98 | 1,489.48 | |
| Trade Receivables | 5,312.32 | 2,200.42 | 2,710.77 | 2,078.74 | 1,149.37 | |
| Cash And Cash Equivalents | 10,998.04 | 7,590.15 | 4,058.71 | 3,367.19 | 2,204.63 | |
| Short Term Loans And Advances | 2,193.25 | 1,244.55 | 1,079.60 | 1,042.67 | 849.17 | |
| OtherCurrentAssets | 2,832.91 | 2,529.87 | 69.51 | 93.88 | 61.15 | |
| Total Current Assets | 29,121.94 | 18,686.46 | 11,801.57 | 10,293.37 | 7,637.55 | |
| Total Assets | 49,027.90 | 29,370.82 | 20,881.21 | 16,474.00 | 12,417.64 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 184.37 | 184.37 | 80.82 | 80.82 | 80.82 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | 1,083.45 | 773.38 | 685.54 | 368.00 | 501.80 | |
| Non-Current Investments Unquoted Book Value | 377.69 | 300.46 | 627.13 | 381.39 | 89.90 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | 188.07 | 19.53 | 0.00 | 37.39 | 79.12 | |
| Current Investments Unquoted Book Value | 1,936.25 | 1,979.53 | 1,305.22 | 1,586.67 | 1,804.23 |
20.11.2025
12.11.2025
11.11.2025
Buy Sun Pharmaceutical Industries; target of Rs 1875 Prabhudas Lilladher
11.11.2025
Sun Pharma Standalone September 2025 Net Sales at Rs 4,548.11 crore, down 11.3% Y-o-Y
11.11.2025
Sun Pharma Standalone September 2025 Net Sales at Rs 4,548.11 crore, down 11.3% Y-o-Y
01.08.2025
Sun Pharma Consolidated June 2025 Net Sales at Rs 13,851.40 crore, up 9.47% Y-o-Y
31.07.2025
Sun Pharma Standalone June 2025 Net Sales at Rs 5,601.96 crore, up 24.54% Y-o-Y
22.05.2025
Sun Pharma Q4 net profit declines 19% to Rs 2,154 crore, firm declares Rs 5.50 dividend